The Safety of Erythropoiesis-Stimulating Agents for the Treatment of Anemia Resulting from Chronic Kidney Disease Nicolas Roberto Robles Review Article 19 February 2016 Pages: 421 - 431
Tumour Risk with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus Patients: A Systematic Review Xia GuoQing YangFupeng Liu Systematic Review 15 March 2016 Pages: 433 - 441
In Vitro and In Vivo Interaction Studies Between Lesinurad, a Selective Urate Reabsorption Inhibitor, and Major Liver or Kidney Transporters Zancong ShenLi-Tain YehMichael Gillen Original Research Article Open access 07 March 2016 Pages: 443 - 452
Health-Related Quality of Life During Routine Treatment with the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-Interventional Observational Study Andreas HornHerbert ZeunerGRAZAX LQ-study group Original Research Article Open access 15 March 2016 Pages: 453 - 462
Pharmacokinetics, Pharmacodynamics and Safety of Multiple-Infusion Ilaprazole in Healthy Chinese Subjects Hongyun WangLiwei LangJi Jiang Original Research Article 11 April 2016 Pages: 463 - 470
Long-Term Efficacy of Tenofovir Disoproxil Fumarate Therapy in Nucleos(t)ide-Experienced Chronic Hepatitis B Patients Mingxing HuangYusheng JieYutian Chong Original Research Article 18 March 2016 Pages: 471 - 478
Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain Javier QuinteroItziar OyagüezMiguel Angel Casado Original Research Article 21 March 2016 Pages: 479 - 490
Factors Related to Early Clinical Effects of Quetiapine Extended-Release: A Multinational, Prospective, Observational Study Luis MolinaByron RecinosSantiago Perez-Lloret Short Communication 28 March 2016 Pages: 491 - 497
Tafluprost Ophthalmic Solution 0.0015 %: A Review in Glaucoma and Ocular Hypertension Gillian M. Keating Adis Drug Evaluation 25 May 2016 Pages: 499 - 508
